These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy. Grimm W, Plachta E, Maisch B. Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513 [Abstract] [Full Text] [Related]
26. An Automatic Algorithm Based on Morphological Stability During Fast Ventricular Arrhythmias Predicts Successful Antitachycardia Pacing in ICD Patients: A Multicenter Study. Matía R, Hernández-Madrid A, Sánchez-Huete G, Martínez-Ferrer JB, Alzueta J, Viñolas X, Rubio J, Porres JM, Rodríguez A, García E, Fernández-Lozano I, Álvarez M, Moreno J. Pacing Clin Electrophysiol; 2016 Jul; 39(7):633-41. PubMed ID: 27019211 [Abstract] [Full Text] [Related]
27. Ventricular tachycardia/fibrillation early after defibrillator implantation in patients with hypertrophic cardiomyopathy is explained by a high-risk subgroup of patients. Alsheikh-Ali AA, Link MS, Semsarian C, Shen WK, Estes NA, Maron MS, Haas TS, Formisano F, Boriani G, Spirito P, Maron BJ. Heart Rhythm; 2013 Feb; 10(2):214-8. PubMed ID: 23041573 [Abstract] [Full Text] [Related]
28. Dual-chamber versus single-chamber detection enhancements for implantable defibrillator rhythm diagnosis: the detect supraventricular tachycardia study. Friedman PA, McClelland RL, Bamlet WR, Acosta H, Kessler D, Munger TM, Kavesh NG, Wood M, Daoud E, Massumi A, Schuger C, Shorofsky S, Wilkoff B, Glikson M. Circulation; 2006 Jun 27; 113(25):2871-9. PubMed ID: 16769912 [Abstract] [Full Text] [Related]
29. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Dorian P, Philippon F, Thibault B, Kimber S, Sterns L, Greene M, Newman D, Gelaznikas R, Barr A, ASTRID Investigators. Heart Rhythm; 2004 Nov 27; 1(5):540-7. PubMed ID: 15851216 [Abstract] [Full Text] [Related]
34. Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population. Buber J, Luria D, Gurevitz O, Bar-Lev D, Eldar M, Glikson M. Europace; 2014 Feb 27; 16(2):227-34. PubMed ID: 24108231 [Abstract] [Full Text] [Related]
36. The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients. Fischer A, Ousdigian KT, Johnson JW, Gillberg JM, Wilkoff BL. Heart Rhythm; 2012 Jan 27; 9(1):24-31. PubMed ID: 21835150 [Abstract] [Full Text] [Related]
37. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial. Gulizia MM, Piraino L, Scherillo M, Puntrello C, Vasco C, Scianaro MC, Mascia F, Pensabene O, Giglia S, Chiarandà G, Vaccaro I, Mangiameli S, Corrao D, Santi E, Grammatico A, PITAGORA ICD Study Investigators. Circ Arrhythm Electrophysiol; 2009 Apr 27; 2(2):146-53. PubMed ID: 19808459 [Abstract] [Full Text] [Related]
38. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S. Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697 [Abstract] [Full Text] [Related]
39. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators. Kouakam C, Lauwerier B, Klug D, Jarwe M, Marquié C, Lacroix D, Kacet S. Am J Cardiol; 2003 Jul 01; 92(1):26-32. PubMed ID: 12842240 [Abstract] [Full Text] [Related]